Larasati Putri Naibaho, Heri Kuswoyo, Sriyatun Sriyatun, Asumsie Tarigan, Khairil Anwar

Comparison Analysis of Short and Long TE on the Clinical Brain Tumor MRS Metabolite Spectrum

Introduction

Comparison analysis of short and long te on the clinical brain tumor mrs metabolite spectrum. Explore MR Spectroscopy (MRS) for brain tumor diagnosis. Compare short & long Time Echo (TE) effects on metabolite spectrum and peak values, essential for precise diagnostic insights.

Abstract

MR Spectroscopy (MRS) can help determine the ratio of brain metabolite spectrum results, in diagnosing brain disorders, especially brain tumors. In MRS, the use of different Time Echo (TE) parameters will affect the results of the metabolite spectrum obtained, as well as the signal intensity at different peak and ratio values. MRS can be performed using short and long TE. This study aims to analyze the differences in peak values in the spectrum of choline, creatine and NAA metabolites and to analyze the comparison of MRS metabolite spectrum results using different TE value variations. The type of research is quantitative analytic with data collection methods using observation, experiments, measurements and literature studies. From the results of the research that has been done, it can be concluded that the use of different short and long TEs affects the results of the spectrum graph, affecting different peak values and ratio values. Both cannot be mutually exclusive, because they have their respective roles in establishing a diagnosis, so the use of this TE variation must be combined in order to establish a diagnosis.

Review

The study titled "Comparison Analysis of Short and Long TE on the Clinical Brain Tumor MRS Metabolite Spectrum" addresses a clinically relevant topic concerning the optimization of Magnetic Resonance Spectroscopy (MRS) protocols for brain tumor diagnosis. MRS is a valuable non-invasive tool for assessing metabolic changes associated with brain pathologies, and the impact of acquisition parameters, particularly Time Echo (TE), on spectral quality and diagnostic accuracy is a critical area of investigation. The authors aim to analyze the differences in key metabolite peak values (Choline, Creatine, NAA) and overall spectral profiles when using short versus long TE values, ultimately seeking to inform optimal MRS strategies in a clinical setting. This objective is well-aligned with the needs of neuroradiology and neuro-oncology. While the study's objective is pertinent, the abstract provides very limited detail regarding the methodological approach, which hinders a thorough evaluation. The description "quantitative analytic with data collection methods using observation, experiments, measurements and literature studies" is too generic and lacks the specificity expected for a scientific journal. Crucially, the abstract omits essential information such as the MRS sequence used, field strength, specific short and long TE values employed, patient cohort size, tumor types studied, and the software used for spectral analysis. Without these details, it is challenging to assess the robustness and generalizability of the findings. The conclusion that "the use of different short and long TEs affects the results of the spectrum graph, affecting different peak values and ratio values" is an expected outcome given the physics of MRS. However, the subsequent assertion that "Both cannot be mutually exclusive, because they have their respective roles in establishing a diagnosis, so the use of this TE variation must be combined in order to establish a diagnosis" requires stronger empirical support and elaboration within the full manuscript to justify the necessity of combination. The abstract does not sufficiently explain *how* they complement each other or *what specific diagnostic insights* are uniquely provided by each TE, thereby necessitating their combined use. To enhance the impact and clarity of this research, the full manuscript should provide a detailed account of the experimental setup, including participant demographics, specific MRS acquisition parameters, and the statistical methods employed. Furthermore, it would be beneficial to elaborate on the distinct diagnostic information provided by short versus long TE spectra in the context of brain tumors. For instance, do short TEs offer better quantification of certain metabolites while long TEs reveal others more clearly, or are there specific tumor types where one TE is demonstrably superior or complementary? Quantifying the improvement in diagnostic confidence or accuracy when combining both TE acquisitions would significantly strengthen the clinical relevance of the findings. Despite the abstract's brevity, the overarching message that a multifaceted MRS approach using varied TEs may be beneficial for comprehensive brain tumor characterization is valuable and warrants further detailed investigation.

Full Text

Comments

You need to be logged in to post a comment.